How Common Is Bipolar Disorder in the U.S. and World?

Bipolar disorder affects roughly 1 in 200 people worldwide, or about 0.5% of the global population. That translates to an estimated 37 million people living with the condition as of 2021, according to WHO data. In the United States, the numbers are notably higher: about 2.8% of adults experienced bipolar disorder in the past year, and 4.4% will experience it at some point in their lives.

Global vs. U.S. Prevalence

The gap between global and U.S. figures is striking, but it doesn’t necessarily mean Americans develop bipolar disorder at higher rates. Differences in diagnostic practices, access to mental health care, and how broadly the condition is defined all play a role. Countries with fewer mental health professionals and less screening infrastructure tend to report lower numbers. The U.S. figures, drawn from the National Institute of Mental Health, also include the full bipolar spectrum, which captures milder forms alongside the classic presentation.

Bipolar I, Bipolar II, and Milder Forms

Bipolar disorder isn’t a single condition. It exists on a spectrum, and the different types vary in how common they are. A large international study pooling data from eleven countries found these lifetime prevalence rates:

  • Bipolar I (full manic episodes): 0.6% of the population
  • Bipolar II (less intense hypomanic episodes with significant depression): 0.4%
  • Subthreshold bipolar (milder mood cycling that doesn’t meet full diagnostic criteria): 1.4%

That last category is the largest group, which helps explain why prevalence estimates vary so much depending on how strictly the diagnosis is applied. When researchers count only classic Bipolar I, the number is relatively small. When they include the full spectrum of mood cycling, the number roughly quadruples. This is one reason you’ll see different statistics in different sources: they’re often measuring different slices of the same spectrum.

When It Typically Appears

Bipolar disorder most often emerges in late adolescence or early adulthood, with the average age of onset falling in the mid-to-late twenties. It can appear earlier or later, but onset after age 40 is uncommon and often prompts clinicians to look for other explanations like medical conditions or medication side effects.

The condition affects men and women at roughly equal overall rates, though there are some differences in how it presents. Women are more frequently diagnosed with Bipolar II and tend to experience more depressive episodes, while men are somewhat more likely to receive a Bipolar I diagnosis with prominent manic episodes.

The Diagnosis Gap

One of the most significant issues with bipolar disorder isn’t how common it is, but how long it takes to identify. On average, it takes about 3.5 years from the first major mood episode to a confirmed Bipolar I diagnosis. That average masks a wide range: roughly one in four people wait five or more years, and about 12% wait a decade or longer.

The delay depends heavily on which type of episode comes first. People whose illness begins with depression wait an average of 5.6 years for a correct diagnosis, compared to 2.5 years for those who first experience mania. This makes sense: a person in the grip of a manic episode is more likely to come to clinical attention quickly, while someone with recurring depression may be treated for depression alone until a manic or hypomanic episode eventually surfaces. During that gap, people often receive incomplete treatment that addresses only half the picture.

The Broader Impact

Bipolar disorder ranks among the top ten causes of years lost to disability worldwide, and its effects extend well beyond mood episodes. People with the condition lose an estimated 65.5 working days per year on average, more than double the 27.5 days lost to major depression. The condition is associated with higher unemployment, greater reliance on public assistance, lower annual income, and reduced life expectancy.

In the U.S. alone, bipolar disorder accounts for an estimated $45 billion in lost productivity and $31.4 billion in direct costs annually. These numbers reflect the reality that bipolar disorder is a chronic condition requiring ongoing management, and that periods of instability can disrupt careers, relationships, and financial security in ways that compound over time. The economic figures also underscore why accurate, timely diagnosis matters so much: the years spent without appropriate treatment carry real and measurable costs for individuals and for the broader health system.